The activation of peroxisome proliferator-activated receptor α (PPAR-α) emerges as a critical mechanism in mitigating NAFLD by promoting anti-inflammatory gene expression and suppressing inflammatory mediators (Bougarne et al., 2018). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.